118 related articles for article (PubMed ID: 24377578)
1. Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines.
Seifi-Alan M; Shamsi R; Ghafouri-Fard S; Mirfakhraie R; Zare-Abdollahi D; Movafagh A; Modarressi MH; Kazemi G; Geranpayeh L; Najafi-Ashtiani M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6625-9. PubMed ID: 24377578
[TBL] [Abstract][Full Text] [Related]
2. STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol in MCF-7 cells and in the rat mammary gland.
Maia CJ; Socorro S; Schmitt F; Santos CR
Endocrine; 2008; 34(1-3):108-16. PubMed ID: 18958632
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines.
Mobasheri MB; Shirkoohi R; Zendehdel K; Jahanzad I; Talebi S; Afsharpad M; Modarressi MH
Tumour Biol; 2015 Sep; 36(10):8201-6. PubMed ID: 25994570
[TBL] [Abstract][Full Text] [Related]
4. shRNA mediated RHOXF1 silencing influences expression of BCL2 but not CASP8 in MCF-7 and MDA-MB-231 cell lines.
Ghafouri-Fard S; Abdollahi DZ; Omrani M; Azizi F
Asian Pac J Cancer Prev; 2012; 13(11):5865-9. PubMed ID: 23317270
[TBL] [Abstract][Full Text] [Related]
5. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer.
Mischo A; Kubuschok B; Ertan K; Preuss KD; Romeike B; Regitz E; Schormann C; de Bruijn D; Wadle A; Neumann F; Schmidt W; Renner C; Pfreundschuh M
Int J Cancer; 2006 Feb; 118(3):696-703. PubMed ID: 16094643
[TBL] [Abstract][Full Text] [Related]
6. Tudor domain-containing protein 4 as a potential cancer/testis antigen in liver cancer.
Yoon H; Lee H; Kim HJ; You KT; Park YN; Kim H; Kim H
Tohoku J Exp Med; 2011 May; 224(1):41-6. PubMed ID: 21515969
[TBL] [Abstract][Full Text] [Related]
7. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.
Yin Y; Sanders AJ; Jiang WG
Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791
[TBL] [Abstract][Full Text] [Related]
8. STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.
Xie J; Yang Y; Sun J; Jiao Z; Zhang H; Chen J
Clin Breast Cancer; 2019 Feb; 19(1):e195-e207. PubMed ID: 30253922
[TBL] [Abstract][Full Text] [Related]
9. Identification of stage-specific breast markers using quantitative proteomics.
Shaheed SU; Rustogi N; Scally A; Wilson J; Thygesen H; Loizidou MA; Hadjisavvas A; Hanby A; Speirs V; Loadman P; Linforth R; Kyriacou K; Sutton CW
J Proteome Res; 2013 Dec; 12(12):5696-708. PubMed ID: 24106833
[TBL] [Abstract][Full Text] [Related]
10. Expression of cGMP-dependent protein kinase, PKGIα, PKGIβ, and PKGII in malignant and benign breast tumors.
Karami-Tehrani F; Fallahian F; Atri M
Tumour Biol; 2012 Dec; 33(6):1927-32. PubMed ID: 22791569
[TBL] [Abstract][Full Text] [Related]
11. Proteinase-activated receptor-2 expression in breast cancer and the role of trypsin on growth and metabolism of breast cancer cell line MDA MB-231.
Matej R; Mandáková P; Netíková I; Poucková P; Olejár T
Physiol Res; 2007; 56(4):475-484. PubMed ID: 16925462
[TBL] [Abstract][Full Text] [Related]
12. BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells.
Yang S; Du J; Wang Z; Yuan W; Qiao Y; Zhang M; Zhang J; Gao S; Yin J; Sun B; Zhu T
BMC Cancer; 2007 Nov; 7():211. PubMed ID: 17997862
[TBL] [Abstract][Full Text] [Related]
13. RHEB expression in fibroadenomas of the breast.
Eom M; Han A; Yi SY; Shin JJ; Cui Y; Park KH
Pathol Int; 2008 Apr; 58(4):226-32. PubMed ID: 18324915
[TBL] [Abstract][Full Text] [Related]
14. The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas.
Dugimont T; Curgy JJ; Wernert N; Delobelle A; Raes MB; Joubel A; Stehelin D; Coll J
Biol Cell; 1995; 85(2-3):117-24. PubMed ID: 8785513
[TBL] [Abstract][Full Text] [Related]
15. [Significance of chemokine receptor CXCR3 expression in breast cancer].
Li L; Chen J; Lu ZH; Yu SN; Luo YF; Zhao WG; Ma YH; Jia CW
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):85-8. PubMed ID: 21426802
[TBL] [Abstract][Full Text] [Related]
16. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
Adams M; Jones JL; Walker RA; Pringle JH; Bell SC
Cancer Res; 2002 Jun; 62(11):3289-97. PubMed ID: 12036947
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated overexpression of the soluble T1-S receptor in lymph node-negative breast cancer.
Werenskiold AK; Prechtel D; Harbeck N; Höfler H
Diagn Mol Pathol; 2000 Mar; 9(1):26-34. PubMed ID: 10718210
[TBL] [Abstract][Full Text] [Related]
19. Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors.
Herrnring C; Reimer T; Jeschke U; Makovitzky J; Krüger K; Gerber B; Kabelitz D; Friese K
Histochem Cell Biol; 2000 Mar; 113(3):189-94. PubMed ID: 10817673
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
